#vasospasm

[the-acid-pear]

I'm laying down holy shit I'm way too cold.my chest hurts I can't feel my fingers either oh Christ ALIVE

#luly talks #nipple vasospasm gonna me number 1 on my suicide letter #when i start blaming ppl of course #blood is going second place for the bit. gonna list tje cause something like not showing pole or something

[lazyyogi]

Ever since high school, I’ve had very cold hands. Sometimes they would vasospasm too, which is called Reynaud’s syndrome.

As I’ve had good results with cold showers, I looked into more Wim Hof methods and one practice involved ice baths for the hands. Basically you submerge in ice water for 2min, then room temp water until normal, and repeat.

I’m going to do this daily for a few weeks and see if any notable changes arise 😁

[lastlycoris]

What surgeries do you have scheduled?

Three surgeries.

Two brain aneurysm coilings. We're going to go through the carotid artery, snake a catheter into the circle of Willis / brain vasculature, and deploy a coil in a sizable anterior cerebral artery aneurysm - an aneurysm is essentially a focal sac that develops in a blood vessel - think of it as a balloon under high pressure - a weakness that can -pop-.

The aneurysms in these cases are big and are at risk of popping with devastating consequences. Unlike the middle meningeal artery I mentioned before, the vessels involved (circle of Willis) directly supply the brain.

Ever experienced a water pipe leak? You have a hole in the water supply somewhere, and you're no longer able to get water from the faucet due to the inadequate water pressure. That's what happens when an aneurysm pops - the brain loses a good portion of its blood supply, and you have what we called a hemorrhagic stroke with all the loss of movement and function that goes with it.

It's actually a bit more complicated than that. Blood is also an irritant in the brain and can cause the brain vessels to constrict in a phenomenon known as vasospasm, which again deprives the brain of oxygen and nutrients.

So we're going to coil these aneurysms off before they pop and do that.

----

Third case is a pituitary macroadenoma resection. Essentially, the guy came into clinic with a very specific visual field loss known as bitemporal hemianopsia - he lost the outermost fields of his vision with the inner part of his field intact.

That specific visual loss pattern tells us that something is affecting the optic nerves in a particular way, specifically the optic chiasm where the two optic nerves share fibers before going to the eyes. We were not surprised to find a pituitary macroadenoma pressing from under the optic chiasm on the head CT - pituitary adenomas are the second most common type of intracranial tumor (meningioma is first).

We are going to remove the tumor by going through his nose and entering into the sphenoid sinus, where the sella turcica is - the place where the pituitary lives. And yes we will be pulling out bits of tumor from his nose.

The advantage of this is that I do not have open up the skull to get to the tumor - and by not opening up the skull, I don't have to interact with the rest of the brain. That is a good thing.

Small thing to worry about is that patient has annoying variant anatomy involving the sphenoid sinus, known as a post-sellar sphenoid sinus. Normally you have a centimeter or so of bone between the sinus and where the brain stem lies. People with post-sellar sphenoid sinuses don't have that.

And yes, poking the brain stem is bad.

--

That's my outpatient schedule for the most part. And then they stuck me on emergent call duties for Trauma for the afternoon / later part of the night.

The things I do to avoid going back to jail.

#🌹~ [ left blooming alone ] || ic #medical rp // #edit : really didn't like the word chiasm

[mcatmemoranda]

Reviewing questions:

Preeclampsia is diagnosed with new-onset hypertension occurring after 20 weeks' gestation with proteinuria. The combination of hypertension and proteinuria during pregnancy is diagnostic for preeclampsia until proven otherwise. Diagnostic criteria:

Hypertension:

Systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg on 2 occasions at least 4 hours apart after 20 weeks of gestation in a previously normotensive patient, or

If systolic blood pressure is ≥160 mmHg or diastolic blood pressure is ≥110 mmHg, confirmation within minutes is sufficient

Proteinuria ≥0.3 g in a 24-hour urine specimen or protein (mg/dL)/creatinine (mg/dL) ratio ≥0.3 or dipstick 1+ if a quantitative measurement is unavailable

In patients with new-onset hypertension without proteinuria, the new onset of any of the following is diagnostic of preeclampsia:

-Platelet count 1.1 mg/dL or doubling of serum creatinine in the absence of other renal disease -Liver transaminases at least twice the normal concentrations -Pulmonary edema -Cerebral or visual symptoms

Preeclampsia usually occurs in the third trimester. If preeclampsia occurs before the third trimester, you should think of gestational trophoblastic disease. Preexisting hypertension increases the risk for intrauterine growth retardation and preeclampsia. Risk factors for preeclampsia include chronic renal disease, chronic hypertension, family history, multiple gestations, nulliparity, a very young woman with her first child, diabetes, and being African American. If the neonate is at term, definitive treatment is delivery. If the neonate is at preterm, the hypertension can be treated with hydralazine, methyldopa, or labetalol. Then, bedrest and observing the patient are advised.

Bottom Line: New-onset hypertension with proteinuria after 20 weeks' gestation is diagnosed as preeclampsia.

The American College of Obstetricians and Gynecologists (ACOG) and most other organizations worldwide continue to recommend magnesium sulfate for seizure prophylaxis and prevention of eclampsia, especially in patients with severe preeclampsia.

ACOG recommends that the decision of whether to use magnesium sulfate for seizure prophylaxis in patients with preeclampsia without severe features be determined using shared decision-making on a patient-by-patient basis. Magnesium sulfate has been shown to be superior to other medical interventions for pregnant women with eclampsia in multiple trials.

Neuromuscular toxicity is the most consistently observed complication of hypermagnesemia. Magnesium is contraindicated in women with myasthenia gravis, as it has been shown to precipitate severe myasthenic crisis. Increased magnesium decreases impulse transmission across the neuromuscular junction. Decreased deep tendon reflexes are usually the first sign of magnesium toxicity and can be seen when the plasma magnesium concentration reaches 7 to 10 mEq/L.

If there is a magnesium drip, it should be stopped at this point. Other side effects of magnesium include respiratory paralysis (10–13 mEq/L), pulmonary edema, hypocalcemia, hyperkalemia, and cardiac arrest (greater than 25 mEq/L). Intravenous calcium gluconate can be administered to reverse severe magnesium sulfate toxicity.

Preeclampsia with severe features requires any one or more of the following factors:

1. Symptoms of central nervous system dysfunction:

New-onset cerebral or visual disturbance, such as:

Photopsia, scotomata, cortical blindness, retinal vasospasm Severe headache (ie, incapacitating, "the worst headache I've ever had") or headache that persists and progresses despite analgesics Altered mental status

2. Hepatic abnormality:

Severe, persistent, right upper quadrant or epigastric pain unresponsive to medication and not accounted for by an alternative diagnosis or serum transaminase concentration ≥ twice normal, or both

3. Severe blood pressure elevation:

Systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥110 mmHg on 2 occasions at least 4 hours apart while the patient is on bedrest (unless the patient is on antihypertensive therapy)

4. Thrombocytopenia:

Less than 100,000 platelets/μL

5. Renal abnormality:

Progressive renal insufficiency (serum creatinine greater than 1.1 mg/dL or doubling of serum creatinine concentration in the absence of other renal disease)

6. Pulmonary edema

Patients may also have HELLP syndrome, which stands for hemolysis, elevated liver function tests, and low platelets. Definitive treatment is delivery if the patient is at term. If preterm, delivery of the neonate is advised once the mother is stabilized to prevent the death of both mother and neonate.

The diagnosis of polyhydramnios is based upon sonographic visualization of increased amniotic fluid volume (AFV). It is diagnosed when there is a single deepest pocket ≥ 8 cm and an amniotic fluid index (AFI) ≥ 24 cm.

The most common cause of severe polyhydramnios are fetal anomalies (often associated with an underlying genetic abnormality or syndrome), while maternal diabetes, multiple gestation, and idiopathic factors are more often associated with milder cases. Polyhydramnios has been associated with fetal anomalies in most organ systems.

Vaginal bleeding is the most common symptom of a complete molar pregnancy and occurs when the molar tissue separates from the decidua. The uterus may also become distended by large pooling of blood, which can overflow into the vaginal vault. This symptom occurs in greater than 95% of cases. Other common symptoms of complete molar pregnancy include hyperemesis, nausea, and signs of hyperthyroidism such as tachycardia, tremor, and warm skin. These findings are a result of markedly elevated beta hCG associated with complete hydatidiform moles. Physical examination typically reveals a uterine size inconsistent with gestational age. Ultrasonography is the gold standard for diagnosis of both complete and partial molar pregnancies and elicits a classic “snowstorm pattern,” or "bunch of grapes" which is simply a mass of heterogenous echogenic material.

Bottom Line: Findings consistent of preeclampsia before 20 weeks, uterine enlargement, disproportional fundal height, and “snowstorm pattern” on ultrasound with no gestational sac all point to the diagnosis of complete molar pregnancy.

There are several key differences between complete and partial hydatidiform mole to be aware of when evaluating a patient with a potential molar pregnancy. Genetically, partial hydatidiform moles are triploid, usually as a result of two sperm fertilizing a normal ovum. Thus, you will see 69 chromosomes (for example, 69XXX or 69XXY) as opposed to a normal 46XY or 46XX in complete hydatidiform mole. Symptomatically, partial molar pregnancies will have fewer sequelae, such as hyperemesis, uterine enlargement or vaginal bleeding, as a result of lower hCG levels than complete molar pregnancies. Finally, a fetus, amniotic fluid and gestational sac can be seen on ultrasound with partial molar pregnancies (sometimes even with fetal heartbeat), whereas no fetus is seen in complete molar pregnancy.

Molar pregnancy tx: It is important to remember that hydatidiform moles are capable of developing into a malignant disease called gestational trophoblastic neoplasm. As such, evacuation of the uterus by dilatation and curettage (D+C) or dilation and evacuation (D+E) is always necessary following this diagnosis.

Clinical chorioamnionitis is an acute ascending, polymicrobial infection of the membranes and chorion of the placenta that can occur in women with prolonged rupture of membranes (defined as greater than 18 hours). Intraamniotic infection occurs in 15-25% of PPROM cases, with a higher incidence occurring at earlier gestational ages. Diagnostic criteria include maternal fever, maternal tachycardia, fetal tachycardia (fetal heart rate > 160/min), leukocytosis, or presence of purulent vaginal discharge. When chorioamnionitis is diagnosed, then IV antibiotics should be started and delivery should occur. In the absence of maternal decompensation or fetal distress, then prompt induction or augmentation of labor is recommended, with a c-section reserved for standard obstetric indications (history of prior CS, fetal distress, fetal malposition, labor dystocia, etc.).

Twin-to-twin transfusion syndrome occurs in monozygotic monochorionic twins and is the result of intrauterine blood transfusion from one twin to another. The donor twin will be small for gestational age; will develop hypovolemia, anemia, and oligohydramnios; and will be oliguric. The recipient twin will be large for gestational age, plethoric, and ruddy and have hypervolemia, polyhydramnios, jaundice, hypertension, and congestive heart failure. This is due to hypoperfusion of the donor twin and hyperperfusion of the recipient twin. Hemoglobin differences are typically greater than 5 g/dL. Hydrops fetalis can present in both twins. Treatment is a reduction amniocentesis.

Radiation exposure less than 50mGy (5 rads) in pregnancy provides negligible risk to the fetus. Radiographic, fluoroscopic, and CT examinations in areas of the body other than the abdomen and pelvis deliver minimal radiation doses to the fetus. Fetal radiation doses from radiographic, fluoroscopic, and CT examinations of the abdomen and pelvis and from nuclear medicine studies rarely exceed 25 mGy. The absolute risks of fetal effects, including childhood cancer induction, are small at conceptus doses of 100 mGy and negligible at doses of less than 50 mGy.

After giving methotrexate to treat an ectopic pregnancy, patients must be carefully followed. The day the methotrexate is given is considered day 1. The β-human chorionic gonadotropin (bHCG) will be checked again on day number 4 and day number 7. It is typical for the bHCG to increase between day 1 and day 4. If it rises during this point, nothing needs to be done. However, between day number 4 and day number 7, the bHCG must decrease by at least 15%. If the bHCG decreases by at least this much, then the bHCG will be checked every week until the level reaches 0. If the bHCG does not decrease by 15%, then another dose of methotrexate is warranted if the patient remains stable and there are no signs of rupture.

Bottom Line: Patients given methotrexate must have bHCG levels followed. From day 4 until day 7, the level must drop by 15%. If it does not, then a second dose of methotrexate is warranted.

COMBANK Insight: There is a single-dose and a two-dose regimen for methotrexate. In the two-dose regimen, a second dose of methotrexate is automatically administered on day 4; otherwise, the regimen steps are the same.

Primary postpartum hemorrhage (PPH) occurs in 1-3% of pregnancies and is defined as 1000 mL of blood loss along with signs of hypovolemia. Causes include uterine atony (most common), bleeding disorders, trauma, and retained placental tissue. Uterine atony can be suspected when there is a history of overdistension (multiple gestations, grand multiparty) or prolonged labor.

Initial treatment includes bimanual or fundic massage. If that fails, uterotonic medications should be given. Oxytocin is usually first-line with the addition of either methylergonovine or carboprost if needed. If that fails, balloon tamponade can be attempted. It is important to assess vitals, hemoglobin/hematocrit, platelets, and coagulation status and initiate volume resuscitation as needed.

When conservative measures fail, the best first approach is uterine artery embolization. This is minimally invasive and has less risk than surgical measures. Conservative surgical options include arterial ligations and compression sutures. Hysterectomy should only be performed if all other measures fail or are unavailable or if there is massive hemorrhage/hemodynamic instability.

#preeclampsia #polyhydramnios #molar pregnancy #chorioamnionitis #twin twin transfusion #ectopic pregnancy #OBGYN #postpartum hemorrhage

[angelnumber27]

What's a vasospasm???

Blood vessels constricting or tightening it doesn’t hurt for some people but it hurts for me lol

[bhushans]

Meeting the Needs of a Growing Population: The Evolving Global Transcranial Doppler Ultrasounds System Market

The global transcranial doppler ultrasounds system market is for transcranial doppler ultrasound systems is expected to reach a turnover of around US$ 646.1 million by 2033, up from US$ 316.8 million in 2023 With a compound annual growth rate (CAGR) of 7.4%.

The need for transcranial doppler ultrasound systems is increasing since they are widely used for imaging diagnosis of stenosis, vasospasm, and emboli caused by subarachnoid hemorrhage.

Gain a Competitive Edge: Request Your Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-5139

TCDs: A Non-Invasive Window into Brain Health

The global transcranial doppler ultrasound (TCD) systems market is experiencing significant growth, driven by the increasing need for effective and non-invasive methods for diagnosing neurological conditions. TCD systems utilize ultrasound waves to measure blood flow velocity within the brain’s basal intracranial arteries.

Broad Spectrum of Applications Fuels Market Growth

The versatility of TCD systems in diagnosing various neurological conditions is propelling market expansion. Key applications include:

Vascular Disorders: TCDs aid in diagnosing stenosis (narrowing), vasospasm (constriction), and emboli (blockages) caused by subarachnoid hemorrhage (bleeding around the brain).

Neurological Conditions: TCDs play a valuable role in identifying arteriovenous malformations (abnormal connections between arteries and veins), cerebral circulatory arrest (blood flow stoppage), and sickle cell disease complications.

Other Applications: TCDs are used in monitoring blood flow during surgery, detecting meningeal infections (inflamed meninges), and evaluating ischemic cerebrovascular disorders (reduced blood flow to the brain).

Key Takeaways:

The global transcranial doppler ultrasound (TCD) systems market is projected to reach US$646.1 million by 2033, reflecting a significant rise from US$316.8 million in 2023.

This growth is anticipated at a strong compound annual growth rate (CAGR) of 7.4% throughout the forecast period.

The rising demand for non-invasive diagnostic tools for neurological conditions is a key driver for market expansion.

Competition Landscape in the Transcranial Doppler Ultrasounds System Market:

According to FMI’s market assessment on transcranial doppler ultrasound systems, there is moderate competition in this industry, which attracts both domestic and overseas enterprises.

In order to strengthen their positions in the market, the industry participants engage in a variety of organic and inorganic tactics, such as alliances, product launches, mergers and acquisitions.

Recent Developments Observed by FMI:

A medical technology and data business called NovaSignal Corp. that specializes in the evaluation and management of brain health announced in March 2022 that Health Canada has approved their NovaGuideTM Intelligent Ultrasound for a Medical Device Licence. Healthcare professionals in Canada may now utilize NovaGuide to record and track the brain’s blood flow in real time.

In order to aid in real-time diagnosis, NovaSignal Inc., headquartered in Los Angeles, introduced a second iteration of their robotic platform in October 2021 that is directed by artificial intelligence (AI). The technology employs ultrasound to automatically record blood flow data, which is subsequently transferred to a cloud system that complies with HIPAA rules so that physicians may view the exam data on any personal device, wherever they are.

Key Players in the Global Market:

ELCAT

Rimed

Natus Medical Incorporated

SMT Medical GmbH & Co. KG

Neural Analytics

Recorders & Medicare Systems Pvt. Ltd.

DX-Systems

Elica

Multigon Industries Inc.

Atys Medica

Transcranial Doppler Ultrasounds System Market Segmentation:

By Product Type:

Wearable

Non-wearable

By Component Type:

Systems

Accessories

By Modality Type:

Standalone

Portable

By End-user:

Hospital

Imaging Diagnostic Centers

Ambulatory Surgical Centers

Others

By Region:

North America

Latin America

Europe

Asia Pacific

Middle East & Africa (MEA)

#Transcranial Doppler Ultrasounds System Market

[tibotai]

Raynaud's disease, also known as Raynaud's phenomenon or Raynaud's syndrome, is a condition characterized by episodes of reduced blood flow to the fingers and toes, causing them to turn pale, cold, and numb. These episodes, known as vasospasms, are often triggered by cold temperatures or emotional stress. Understanding the types, symptoms, causes, and treatment options for Raynaud's disease is crucial for effective management and symptom relief.

Types of Raynaud's Disease:

Primary Raynaud's: Also called Raynaud's disease, this type occurs without an underlying medical condition. It is the most common form and tends to be less severe.

Secondary Raynaud's: Also known as Raynaud's phenomenon, this type is associated with an underlying health condition, such as autoimmune diseases like lupus or scleroderma, vascular diseases, or injuries to the hands and feet.

Symptoms of Raynaud's Disease:

Color Changes: Affected areas, typically the fingers and toes, may turn white (pallor), then blue (cyanosis), and finally red (hyperemia) as blood flow returns.

Cold Sensation: Patients often experience a sensation of coldness or numbness in the affected digits during an episode.

Numbness or Tingling: Tingling or a pins-and-needles sensation may accompany the color changes.

Throbbing or Pain: As blood flow returns, affected areas may throb or feel painful.

Ulcers or Gangrene: In severe cases, repeated episodes of reduced blood flow can lead to the development of ulcers or even tissue death (gangrene).

Causes of Raynaud's Disease:

Vasospasm: The primary cause of Raynaud's disease is believed to be an exaggerated response of the blood vessels to cold or emotional stress, leading to spasms and reduced blood flow.

Underlying Conditions: Secondary Raynaud's is often associated with underlying health conditions that affect blood vessel function, such as autoimmune diseases, vascular diseases, or injuries.

Genetic Factors: There may be a genetic predisposition to developing Raynaud's disease, as it sometimes runs in families.

Environmental Triggers: Cold temperatures, emotional stress, smoking, and certain medications can trigger or exacerbate Raynaud's symptoms.

Treatment Options for Raynaud's Disease:

Lifestyle Modifications: Avoiding cold temperatures, wearing warm clothing, and managing stress can help reduce the frequency and severity of Raynaud's episodes.

Medications: Calcium channel blockers, which help dilate blood vessels, are commonly prescribed to improve blood flow and reduce the frequency of vasospastic episodes. Other medications, such as alpha-blockers and vasodilators, may also be used in some cases.

Biofeedback Therapy: This technique helps patients learn to control their body temperature and blood flow using relaxation and visualization techniques.

Surgery: In severe cases where other treatments have been ineffective, surgical procedures such as sympathectomy (surgical interruption of nerve pathways) may be considered.

Avoiding Triggers: Identifying and avoiding triggers such as cold temperatures, emotional stress, and certain medications can help manage symptoms.

Conclusion:

Raynaud's disease is a common condition characterized by episodes of reduced blood flow to the fingers and toes, leading to color changes, cold sensations, and numbness. While primary Raynaud's often requires only lifestyle modifications for management, secondary Raynaud's may necessitate treatment of the underlying condition. With proper understanding and management, individuals with Raynaud's disease can minimize symptoms and improve their quality of life. If you suspect you have Raynaud's disease, consult a healthcare professional for diagnosis and personalized treatment recommendations.

[mrfr-blogs]

Unveiling the Research Behind Cardiac Catheterization Market Services

Market Overview –

The Cardiac Catheterization Market encompasses medical procedures and equipment used to diagnose and treat heart conditions through minimally invasive techniques. Cardiac catheterization involves inserting a catheter into a blood vessel and guiding it to the heart to perform diagnostic tests, visualize blood flow, and deliver therapeutic interventions such as angioplasty and stent placement.

One significant driver of the Cardiac Catheterization Market's growth is the increasing prevalence of cardiovascular diseases globally. Conditions such as coronary artery disease, heart failure, and valvular heart disease contribute to the growing demand for cardiac catheterization procedures as clinicians seek to diagnose and manage these conditions promptly.

Advancements in catheterization techniques, imaging technologies, and interventional cardiology devices have also fueled market growth by improving procedural outcomes, reducing complications, and expanding the scope of minimally invasive cardiac interventions. Additionally, the shift towards outpatient procedures and same-day discharge protocols has increased the efficiency and accessibility of cardiac catheterization services, driving further demand.

Moreover, the aging population and the rising adoption of sedentary lifestyles contribute to the increasing burden of cardiovascular diseases, further driving the demand for cardiac catheterization procedures. As healthcare systems prioritize preventive cardiology, early diagnosis, and timely intervention, the Cardiac Catheterization Market is expected to continue growing, offering opportunities for innovation and collaboration among medical device manufacturers, healthcare providers, and researchers.

The Cardiac Catheterization Market, often referred to as the cardiology catheter market, is experiencing significant growth attributed to advancements in minimally invasive procedures for diagnosing and treating heart conditions. With a rise in cardiovascular diseases globally, the demand for these catheters is increasing, propelling market expansion.

The Cardiac Catheterization Market was valued at USD 0.35 billion in 2022. The Cardiac Catheterization market is expected to increase from USD 0.3731 billion in 2023 to USD 26.4 billion by 2032, with a compound yearly growth rate (CAGR) of 7.4% over the forecast period (2023-2032).

Market Segmentation –

The market is segmented into five Key dynamics for an easy grasp.

By Procedures: Balloon Septostomy, Coronary Angioplasty, Catheter Ablation, Bipolar Pacing, Left Heart Catheterization, and Right Heart Catheterization among others.

By Types: Fractional Flow Reserve, Coronary Angiogram, Intravascular Ultrasound, and Optical Coherence Tomography among others.

By Applications: Heart Attack, Abnormal Stress Test, Coronary Vasospasm, and Cardiac Arrhythmia, among others.

By End-Users: Hospitals and Clinics among others.

By Regions: Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Regional Analysis –

The regional analysis of the cardiac catheterization market reflects disparities in healthcare infrastructure, prevalence of cardiovascular diseases, and adoption of minimally invasive procedures. North America leads the market, driven by advanced healthcare facilities, high prevalence of cardiovascular conditions, and early adoption of innovative technologies. Europe follows suit, with robust investments in healthcare infrastructure and increasing demand for minimally invasive cardiac procedures. In the Asia-Pacific region, improving access to healthcare services, rising disposable incomes, and growing awareness about cardiovascular health contribute to market growth. Developing regions in Latin America and Africa are also witnessing gradual market expansion as healthcare infrastructure improves and awareness about cardiovascular diseases increases.

Key Players –

Cardiac catheterization market Key companies include St. Jude Medical (US), Medtronic Inc. (US), Becton, Dickinson, and Company (US), Terumo Medical Corporation (Japan), Teleflex Incorporated (US), Edwards Life Sciences Corporation (US), Abbott (US), Boston Scientific Corporation (US), Rochester Medical Corporation (US), Johnson & Johnson Private Limited (US), Dispocard GmbH (Germany), Maquet Medical India Private Limited (India), and Coloplast (Denmark).

Related Reports –

US Melanoma

Middle East and Africa HIV Diagnosis & Treatment

Gastroparesis Treatment

Dental Infection Treatment

For more information visit at MarketResearchFuture

#Cardiac Catheterization Market #Cardiac Catheterization Market Size #Cardiac Catheterization Market Share #Cardiac Catheterization Market Trends #Cardiac Catheterization Market Growth

[tamacathers]

Day 5 - Minos - October 2 

Today was awesome.  Since Margaret was feeling so poorly yesterday, she decided to take a rest day. So I was set to hike alone… Well…’alone’ is a relative term on the Camino. I am doing pretty well, able to hike with my Coronary Microvascular Dysfunction (CMD), but I still get vasospasms that cause heart pain. I lowered my beta-blocker dose from 2 pills to 1.5 and I didn’t start out with a…

View On WordPress

[infinitiresearch]

Transcranial Doppler Market| Market Size, Analysis and Forecast, 2024 – 2028

Originally published on Technavio: Transcranial Doppler Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, India, Germany, France - Size and Forecast 2024-2028

The transcranial Doppler (TCD) market holds a significant position within the medical imaging and diagnostics sector, focusing specifically on non-invasive monitoring of blood flow within the brain. Transcranial Doppler ultrasound technology allows healthcare professionals to assess cerebral blood flow velocities and detect abnormalities or conditions such as strokes, vasospasms, and intracranial stenosis. This market caters to a range of medical applications, including neurology, neurosurgery, and critical care, where monitoring cerebral blood flow is essential for diagnosis and treatment planning.

One of the key drivers of the transcranial Doppler market is the increasing incidence of neurological disorders and cerebrovascular diseases. As the global population ages, the prevalence of conditions such as strokes and neurovascular disorders rises, necessitating advanced diagnostic tools. Transcranial Doppler ultrasound provides a non-invasive and real-time method for healthcare professionals to assess cerebral blood flow, aiding in the early detection and management of various neurological conditions.

Technological advancements in transcranial Doppler devices have played a pivotal role in the market's growth. Modern TCD systems are equipped with features such as color imaging, spectral analysis, and Doppler signal processing algorithms, enhancing the accuracy and reliability of cerebral blood flow measurements. These technological innovations contribute to the efficiency of diagnosis and enable healthcare providers to obtain detailed information about blood flow patterns in different cerebral vessels.

The transcranial Doppler market is closely aligned with broader trends in healthcare, emphasizing the importance of non-invasive and cost-effective diagnostic tools. As healthcare systems seek to improve patient outcomes and reduce the burden of invasive procedures, transcranial Doppler ultrasound offers a valuable solution for assessing cerebrovascular health. Its applications extend beyond diagnostic purposes, as TCD monitoring is increasingly used in critical care settings to guide interventions and assess treatment effectiveness in real-time.

The impact of the COVID-19 pandemic on the transcranial Doppler market has been influenced by shifts in healthcare priorities and resource allocation. While the pandemic strained healthcare systems, the importance of efficient and non-invasive diagnostic tools remained evident. Transcranial Doppler, with its ability to provide valuable insights into cerebral blood flow without the need for invasive procedures, has maintained its relevance in neuroimaging and diagnostics during challenging times.

To Learn deeper into this report , View Sample PDF

Looking ahead, the transcranial Doppler market is poised for continued growth as advancements in technology and increasing awareness of neurological health drive demand. The integration of artificial intelligence (AI) and machine learning algorithms into TCD systems may further enhance diagnostic capabilities and contribute to personalized treatment approaches. As the importance of cerebrovascular health gains prominence in preventive medicine, the transcranial Doppler market is likely to play a critical role in shaping the future of neuroimaging and diagnostics, offering non-invasive and effective solutions for healthcare professionals and patients alike.

For more information please contact.

[qqdahao]

Can mild coronary heart disease eat Tongxinluo capsule?

Atherosclerosis is an important pathogenic factor of coronary heart disease. in the treatment of coronary heart disease, Tongxinluo capsule is a commonly used drug, which can significantly reduce the first cardiovascular events in patients with atherosclerosis. But coronary heart disease is also divided into priorities, specific to each person's physique is also different, so there is no unified standard. So mild coronary heart disease can eat Tongxinluo capsule? Let's talk about this topic today.

In life, there are many patients with mild coronary heart disease, the symptoms do not seem to be very serious, clinically, and the hospital also has a common rule, that is, mild heart disease, does not reach a certain target, does not need treatment, regular review will be fine. If it develops to have obvious symptoms, consider treatment. Therefore, many patients with mild coronary heart disease tend to use traditional Chinese medicine after they find that they have shortness of breath, chest tightness, and shortness of breath, although they do not know whether it is right to do so.

Coronary heart disease is caused by coronary artery stenosis and blockage, and there are many kinds of coronary artery stenosis and blockage, some mild stenosis, some moderate or severe. Different patients have different degrees of coronary artery stenosis or occlusion, some mild coronary heart disease will not have any clinical symptoms but also need standardized drug treatment to prevent the progression of coronary artery stenosis and cause adverse events such as acute myocardial infarction. So mild coronary heart disease can eat Tongxinluo capsule?

The occurrence of cardio-cerebrovascular disease is not only related to the degree of lumen stenosis but also depends on the stability of plaque. Once the unstable plaque is ruptured, it can even cause disability and death within a few minutes. Therefore, in the treatment of coronary heart disease, drugs should stabilize and reduce plaque and dredge blood vessels at the same time.

Tongxinluo capsule can comprehensively interfere with the whole process of atherosclerosis, regulating lipid, anti-inflammation, and anticoagulation, protecting vascular endothelium, stably reversing plaque, relieving vasospasm, protecting microvessels, and improving cardio-cerebral ischemia. From the common pathological basis of cardio-cerebrovascular diseases (endothelial injury and vasospasm) to the formation of atherosclerotic plaques, it plays a comprehensive role in vascular protection. It can also improve the long-term survival rate and quality of life of patients with cardiovascular and cerebrovascular diseases, and achieve the goal of systematic intervention and lifelong benefit.

#yiling

[srishtiivf]

Nipple Pain and Soreness Relief: Conquering Common Breastfeeding Problems

Breastfeeding is a beautiful and natural way to nourish your baby, but it can also come with its fair share of challenges. One of the most common breastfeeding problems that mothers face is nipple pain and soreness. While this discomfort can be discouraging, it's essential to remember that it's a common issue and, with the right strategies, can be effectively managed. In this article, we will explore the causes of nipple pain and soreness during breastfeeding and provide practical tips to find relief and continue your breastfeeding journey comfortably.

Understanding the Causes

Nipple pain and soreness can have several underlying causes. It's crucial to identify the source of your discomfort to implement the most effective solutions. Here are some common causes:

Improper Latch: A poor latch is one of the primary culprits behind nipple pain. When the baby doesn't latch correctly, it can lead to friction and irritation on the nipple's sensitive skin.

Engorgement: Swollen and engorged breasts can make latching more challenging and increase the pressure on your nipples, causing soreness.

Thrush: A fungal infection known as thrush can be passed between mother and baby, causing nipple pain and discomfort.

Nipple Vasospasm: Vasospasm can occur when the blood vessels in the nipple constrict due to pressure or cold, resulting in sharp, shooting pain.

Nipple Trauma: Rough handling, using the wrong breast pump settings, or a baby with a strong suck can lead to nipple trauma and pain.

Relief Strategies

Now that we've identified the common causes, let's explore strategies to relieve nipple pain and soreness:

Correct Latch and Positioning: Ensuring your baby has a proper latch is key to preventing nipple pain. Seek assistance from a lactation consultant or a knowledgeable healthcare provider to assess and improve your baby's latch and positioning.

Warm Compresses: Applying a warm compress to your breasts before feeding can help alleviate engorgement and promote better milk flow.

Nipple Creams: Use lanolin-based nipple creams to soothe and moisturize sore nipples. Make sure to choose creams that are safe for both you and your baby.

Pain Medication: Over-the-counter pain relievers, such as ibuprofen, can help manage pain and reduce inflammation. Consult your healthcare provider before taking any medication while breastfeeding.

Address Underlying Issues: If you suspect thrush or nipple vasospasm, consult your healthcare provider for a proper diagnosis and treatment plan.

Breast Shields: Nipple shields can provide a barrier between your nipple and your baby's mouth, reducing direct friction and providing relief during feeds.

Express Milk Gently: If using a breast pump, ensure that it's set to the right suction level and use a soft, comfortable breast shield to avoid further trauma to your nipples.

Conclusion

Breastfeeding problems like nipple pain and soreness are common but can be managed effectively with the right strategies and support. Remember that seeking help from a lactation consultant or healthcare provider is crucial if the pain persists or worsens. With patience, perseverance, and proper care, you can overcome nipple pain and continue to enjoy the benefits of breastfeeding for both you and your precious little one.

[psychosynchrony]

I'm tired and need to vent a bit.

My hands have been hurting for months.

Now, I've experienced Reynaud's Phenomenon since 8th grade, but it was always like... a mild inconvenience? Sometimes there's wacky vasospasm things, it happens. Mostly in the winter or in the A/C. nbd. I wear gloves, keep handwarmers in the car, etc.

But last winter it started to hurt. It wasn't just "ugh my hands have no circulation right now and turn funky colors" it was "ow there's no circulation and ALSO they're stiff and achey."

So I saw my doctor, who ordered about a dozen lab tests to check for arthritis or some other inflammatory thing.

All negative.

So then there's the awful voice in the back of my head like "maybe it's not that bad?" Because I haven't lost range of motion, and my hands look pretty normal.

But they hurt. And I type for a living (and for leisure, because I like to game), so it's not ignorable. Every day, all day, it's just this constant ache through all my finger joints, regardless of whether there's a vasospasm at the time or not. It's just always there, and I think it's getting worse. Still navigable, but even small pains are exhausting when they don't go away.

So yeah. That's where I'm at.

#personal #health

[rohans18]

Cerebral Vasospasm Market CAGR, Trends, Top Players, Analysis, Industry Size - Forecast 2028

Global Cerebral Vasospasm Market, By Diagnosis (CT Scan, Computed Tomography Angiography (CTA), Digital Subtraction Angiography (DSA), Magnetic Resonance Angiography (MRA) and Transcranial Doppler (TCD)), Treatment (Nimodipine, Triple-H Therapy, Balloon Angioplasty, Vasopressors, Inotropes, Thrombolytic Agents and Anti-inflammatory Agents), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Trauma Centers, Emergency Departments, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

In the consistent Cerebral Vasospasm market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Cerebral Vasospasm industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Cerebral Vasospasm market report brings precise and exact market research information that drives business into the right direction.

Key Players

The major players covered in the Cerebral Vasospasm market report are ABELDent Inc., Dentimax, Carestream Health, Henry Schein One, YAPI Inc., ACE Dental, Datacon Dental Systems, KaVo Dental, SMK Imaging, Open Cerebral Vasospasm, PLANMECA OY, Dentsply Sirona, Consult-PRO, Patterson Companies Inc., NF Dental Group, Curve Dental, LLC, PRACTICE-WEB INC., NXGN Management, LLC, BestoSys Solutions Private Limited and Allscripts Healthcare, LLC among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-cerebral-vasospasm-market

The research studies entailed in the winning Cerebral Vasospasm market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Cerebral Vasospasm Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

[symptomfinder]

Vasospasm nipple symptoms can be a painful and frustrating experience for many women. This condition occurs when the blood vessels in the nipple constrict, causing a decrease in blood flow and oxygen to the area. This can lead to symptoms such as nipple pain, discoloration, and sensitivity. While vasospasm nipple symptoms can be uncomfortable, it is important to understand that they are not uncommon. Many women experience this condition, especially during breastfeeding. Fortunately, there are steps that can be taken to alleviate symptoms and prevent future occurrences. Understanding the causes and treatments of vasospasm nipple symptoms can help women feel more in control of their bodies and their breastfeeding experience. If you are experiencing vasospasm nipple symptoms, it is essential to seek medical attention. Your healthcare provider can help you determine the cause of your symptoms and recommend appropriate treatment. With the right care and support, you can manage your symptoms and continue to breastfeed your baby. By learning more about vasospasm nipple symptoms, you can take an active role in your health and well-being.1. What is Vasospasm and How Does it Affect Nipples?Vasospasm is a condition where blood vessels in the nipple constrict and restrict blood flow. It can cause pain, discoloration, and sensitivity. It can be triggered by cold temperatures, stress, or breastfeeding. Treatment includes warm compresses, medication, and avoiding triggers. 😞 Vasospasm can affect breastfeeding mothers, causing pain during and after feeding. It can also lead to nipple damage and infection. It's important to seek medical attention if symptoms persist. 🤱 Risk factors for vasospasm include smoking, Raynaud's disease, and poor circulation. It's more common in women with a history of breast surgery or trauma. Prevention includes keeping nipples warm, avoiding tight clothing, and managing stress. 🚫👚 Diagnosis involves a physical exam and ruling out other conditions. An ultrasound or mammogram may be ordered. Treatment options include calcium channel blockers, pain relievers, and topical creams. 🩺💊 In conclusion, vasospasm is a painful condition that can affect nipples and breastfeeding. It's important to seek medical attention and take steps to prevent and manage symptoms. Talk to your healthcare provider if you have concerns. 🙏2. Common Symptoms of Vasospasm Nipple Pain and Discomfort Vasospasm can cause nipple pain and discomfort. The pain is usually sharp, stabbing, or burning. The discomfort can last from a few seconds to several minutes. The pain may be worse during or after breastfeeding. Nipples may appear white or blanched. The pain may be triggered by cold temperatures. Some women may experience nipple sensitivity or itching. Vasospasm can also cause breast pain or discomfort. 👀 If you experience any of these symptoms, contact your healthcare provider for an evaluation. Early diagnosis and treatment can help relieve discomfort and prevent complications. 💪3. Causes and Risk Factors of Vasospasm Nipple Symptoms Vasospasm nipple symptoms can be caused by several factors, including: Poor latch during breastfeeding Raynaud's phenomenon Smoking Exposure to cold temperatures Other risk factors that can contribute to vasospasm nipple symptoms include: History of breast surgery Use of certain medications Underlying medical conditions such as lupus or scleroderma It's important to note that not all women who experience these risk factors will develop vasospasm nipple symptoms. However, it's essential to be aware of these factors and take steps to minimize their impact. If you're experiencing vasospasm nipple symptoms, it's essential to seek medical attention to determine the underlying cause. Treatment options may include medication, changes in breastfeeding technique, or lifestyle modifications. Remember, early diagnosis and treatment can help alleviate symptoms and prevent complications. Don't hesitate to speak with your healthcare provider if you're experiencing any discomfort or unusual symptoms related to breastfeeding. 4. Diagnosis and Treatment Options for Vasospasm Nipple SyndromeDiagnosis of vasospasm nipple syndrome involves a physical examination and a thorough medical history. Symptoms include nipple pain, discoloration, and sensitivity. Treatment options include warm compresses, topical creams, and pain medication. Lifestyle changes such as quitting smoking and reducing caffeine intake may also help. In severe cases, a doctor may prescribe calcium channel blockers or surgery. It's important to seek medical attention if symptoms persist or worsen. Support groups and counseling can also provide emotional support and coping strategies. Remember, early diagnosis and treatment can improve quality of life. 😊5. Coping Strategies for Managing Vasospasm Nipple SymptomsWhen experiencing vasospasm nipple symptoms, there are several coping strategies that can help manage the discomfort. Wear warm clothing to promote blood flow. Use warm compresses to relax the muscles. Avoid tight-fitting bras and clothing. Practice relaxation techniques like deep breathing and meditation. Consider taking pain medication prescribed by your doctor. It's important to communicate with your healthcare provider about any symptoms you're experiencing. They may recommend additional treatments or adjustments to your current plan. Remember to prioritize self-care and take breaks when needed. Stress can exacerbate symptoms, so finding ways to relax and unwind can be beneficial. Support from loved ones can also be helpful. Don't be afraid to reach out for help or talk about your experiences with others. Overall, managing vasospasm nipple symptoms can be challenging, but with the right strategies and support, it's possible to find relief and improve your quality of life. 💪🏼6. Prevention Techniques for Reducing the Frequency of Vasospasm Nipple EpisodesPreventing vasospasm nipple episodes is crucial for breastfeeding mothers. Here are some techniques to reduce their frequency: Keep warm: Wear warm clothing and keep your nipples warm to prevent constriction of blood vessels. Proper latching: Ensure your baby latches onto the breast correctly to avoid nipple damage. Limit caffeine: Caffeine can cause vasoconstriction, so limit your intake of coffee, tea, and chocolate. Massage: Gently massage your breasts before and after breastfeeding to improve blood flow. Stay hydrated: Drink plenty of water to keep your body hydrated and prevent vasoconstriction. Use a warm compress: Apply a warm compress to your breasts before breastfeeding to improve blood flow. By following these techniques, you can reduce the frequency of vasospasm nipple episodes and enjoy a more comfortable breastfeeding experience. 🤱🏻 In conclusion, understanding vasospasm nipple symptoms is crucial for those who experience them. It's important to know that this condition is not harmful to your health, but it can be uncomfortable. If you're experiencing nipple pain, discoloration, or sensitivity, consult with your healthcare provider to determine if vasospasm is the cause. Don't let vasospasm nipple symptoms go untreated. By seeking medical attention, you can alleviate discomfort and find relief. Remember to keep warm, stay hydrated, and avoid triggers like caffeine and nicotine. With proper care, you can manage this condition and live comfortably. 💪🏼💊🩺 https://symptomfinder.com/understanding-vasospasm-nipple-symptoms/?_unique_id=647f564f65e4a

#Uncategorised #Breastfeedingvasospasmsymptoms #Nippleblanchingpain #Raynaudsphenomenonnipple #Vasospasmbreastfeedingtreatment #Vasospasmnipplepain #aiomatic_0

[shinu1425452]

Stroke Management

Stroke is an emergency condition that needs immediate treatment depending upon the type of the stroke. Quick treatment improves chances of survival and reduces complications.

 Ischemic stroke:In cases of ischemic stroke, treatment is done to quickly restore blood flow to the brain.

Emergency medication for Ischemic stroke: Emergency treatment includes clot-busting drugs that dissolve blood clot. Drugs include:

Aspirin

Intravenous injection of recombinant tissue plasminogen activator (TPA)

Emergency procedures: Depending upon the features of bold clot, surgeon may decide to perform following procedure in patients of ischemic stroke:

Medications delivered directly to the brain through a long, thin tube called catheter to deliver TPA directly into the area of stroke.

Mechanical clot removal is done using a catheter to maneuver a tiny device into the brain that will physically break up or grab and remove the clot.

Other procedures: Following procedures are recommended by the surgeon to decrease the risk future stroke:

Carotid endarterectomy is a surgical procedure that removes plaques from carotid arteries to reduce the risk of ischemic stroke.

Angioplasty and stents is a procedure in which surgeon gains access to the carotid artery through an artery in the groin and expands the narrowed artery by using a balloon. Now a stent is inserted to support the opened artery.

Hemorrhagic stroke: In case of hemorrhagic stroke, treatment is done to control bleeding and reduce pressure in the brain.

Emergency medication for hemorrhagic stroke: Patients taking warfarin (coumadin) or other anti-platelet drugs such as clopidogrel (Plavix) to prevent blood clots are given drugs to counteract their blood thinners’ effects. In addition to this, drugs to lower pressure in brain (intracranial pressure), lower blood pressure, prevent vasospasm or prevent seizures. After bleeding stops in brain, supportive medical care is given to absorb blood and fasten healing.

Surgical blood vessel repair: Any of the following procedures is done to repair blood vessel abnormalities associated with hemorrhagic stroke:

Surgical clipping to stop blood flow, prevent bursting of aneurysm or to prevent re-bleeding of an aneurysm.

Coiling (endovascular embolization) is a procedure to insert a catheter into an artery to attach tiny detachable coils into the aneurysm. This will block the blood flow into the aneurysm.

Surgical removal of accessible AVM to eliminate the risk of rupture and lower the risk of hemorrhagic stroke.

Intracranial bypass is the procedure of bypassing intracranial blood vessels to treat poor blood flow to a region of the brain or complex vascular lesions.

Stereotactic radiosurgery is an advanced minimally invasive treatment used to repair vascular malformations

#strokemanagmentpune